GlassScriptPhysician profile
Katie Riegle
NPI 1245509660
$6,473.34
in general payments reported to CMS, 2019-2025
46 companies · $690 in 2025
The $690 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,646 · 2022: $1,669 · 2023: $2,033 · 2024: $436 · 2025: $690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,158.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $933.91 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $832.53 | 2021-2025 | |
| Novo Nordisk INC | $617.37 | 2021-2023 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $608.35 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $488.60 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $302.99 | 2021-2025 | |
| Pfizer INC. | $282.80 | 2021-2025 | |
| Amgen INC. | $264.85 | 2021-2025 | Repatha, Otezla, Evenity |
| Merck Sharp & Dohme LLC | $191.44 | 2021-2023 | Dificid |
| Sunovion Pharmaceuticals INC. | $149.90 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $131.50 | 2023 | Gemtesa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $127.46 | 2023 | Trulance, Xifaxan, Relistor |
| Acclarent, INC | $117.06 | 2023 | Acclarent Aera |
| Novartis Pharmaceuticals Corporation | $114.12 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $107.49 | 2022-2024 | Xarelto, Spravato, Invokana |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Riegle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.